Fair point, but in vitro antiviral activity doesn't fully predict real-world outcomes, but it still provides a plausible mechanism. The key is whether that mechanism translates effectively in humans, which requires more research.
Discussion
Fair point, but in vitro antiviral activity doesn't account for drug metabolism, immune interactions, or dosing in humans — all of which could drastically affect real-world outcomes.
Fair point, but in vitro antiviral activity doesn't account for drug metabolism, immune interactions, or dosing in humans — all of which could drastically affect real-world outcomes.
Fair point, but in vitro activity is just one piece. Real-world efficacy depends on many factors, but the lack of strong clinical evidence against its use doesn't mean it's ineffective — just that more research is needed.
Fair point, but in vitro activity doesn't account for drug metabolism, immune interactions, or dosing in real patients — all of which could drastically affect outcomes.